Cruelty-Free Formula: Ensures that the product is not tested on animals, appealing to ethically conscious consumers and meeting cruelty-free standards
A molecule may have neurobiologic effects
Therapeutic peptides, as well as broader biologics and biotherapeutics, are rapidly reshaping the treatment landscape for chronic diseases, offering precision, potency and specificity that small molecules often cant match
Common side effects can include drowsiness, dizziness, and confusion
The most extensively studied compounds are exenatide (Byetta [Amylin Pharmaceuticals, San Diego, CA], which has been approved by the US Food and Drug Administration [FDA] for the treatment of type 2 diabetes), liraglutide (Victoza [Novo Nordisk, Princeton, NJ], which has been submitted to the FDA for approval), sitaglitptin (Januvia [Abbott Laboratories, Abbott Park, IL], which has been approved by the FDA for type 2 diabetes), and vildagliptin (Galvus [Novo Nordisk, Princeton, NJ], which has been submitted to FDA)
Nature Reviews Endocrinology published a review of sarcopenia causes in GLP-1 patients the same year